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Exposure to high levels of ionizing radiation (IR) leads to debilitating and dose-limiting gastrointestinal
(GI) toxicity. Using three-dimensional mouse crypt culture, we demonstrated that p53 target PUMA
mediates radiation-induced apoptosis via a cell-intrinsic mechanism, and identified the GSK-3 inhibitor
CHIR99021 as a potent radioprotector. CHIR99021 treatment improved Lgr51 cell survival and crypt
regeneration after radiation in culture and mice. CHIR99021 treatment specifically blocked apoptosis and
PUMA induction andK120 acetylation of p53mediated by acetyl-transferase Tip60, while it had no effect on
p53 stabilization, phosphorylation or p21 induction. CHIR99021 also protected human intestinal cultures
from radiation by PUMA but not p21 suppression. These results demonstrate that p53 posttranslational
modifications play a key role in the pathological and apoptotic response of the intestinal stem cells to
radiation and can be targeted pharmacologically.
R adiation therapy continues to serve as a leading cancer treatment. However, exposure to high levels ofionizing radiation (IR) leads to acute gastrointestinal (GI) injury and development of GI syndrome1. Thistoxicity is the most significant dose-limiting factor in abdominal radiotherapy, and there is currently no
FDA-approved agent for its prevention or treatment2–4. The intestinal epithelium undergoes rapid and continu-
ous renewal fueled by the intestinal stem cells (ISCs) located at the bottom of crypts, including fast cycling crypt
base columnar cells (CBCs) and more quiescent ‘‘14’’ cells above Paneth cells (PCs) in mice5–7. Lgr5 can mark
both cells, while Bmi1 and HopX were reported to preferentially mark14 cells7. Loss of clonogenic or stem cells
plays a key role in radiation-induced acute intestinal injury and lethality1, and is regulated by the p53 pathway and
its transcriptional targets PUMA and p214,8–10. PUMA-dependent apoptosis rapidly depletes ISCs and progeni-
tors in hours following high dose radiation, and PUMA deficiency results in enhanced animal survival and crypt
regeneration via p21-dependent DNA repair11,12.
Glycogen synthase kinase 3 (GSK-3) is an essential serine/threonine protein kinase consisting of two isoforms,
GSK-3a and GSK-3b, that regulates a wide variety of cellular functions such as metabolism, proliferation and
survival13,14. Numerous GSK-3 inhibitors have been developed and used in functional studies, including non-
selective Lithium, and more selective small molecules such as SB216763, SB415286 and CHIR9902114,15. The
regulation of GSK-3b is complex and highly tissue-specific, and it has both pro- and anti-apoptotic functions15.
For example, GSK-3b is required for normal development and inhibits the canonicalWnt pathway by promoting
the degradation of b-catenin15. GSK-3b can promote apoptosis in response to DNA damage in neurons16–18, and
growth factor-mediated activation of PI3K/AKT phosphorylates and inhibits GSK-3b19. p53 is extensively modi-
fied after DNA damage20, and K120 acetylation of p53 is linked to induction of PUMA and apoptosis after
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radiation and mediated by GSK-3-dependent phosphorylation of
Tip60 at S86 in some cancer cells21–23. The role of GSK-3 in the
DNA damage response of intestinal stem cells remained undefined.
Radiation-induced intestinal injury and protection has tradition-
ally been studied in mice4. In the present study, using a three-dimen-
sional (3D) in vitro intestinal crypt culture system24, we
demonstrated a cell-intrinsic role of p53 and PUMA-dependent
apoptosis in radiation-induced intestinal injury, and identified the
GSK-3 inhibitor CHIR99021 as a potent intestinal radiation pro-
tector. Our findings in mouse and human intestinal cultures and
whole mouse, indicated that CHIR99021 treatment strongly protects
Lgr51 ISCs by selectively inhibiting p53-dependent induction of
PUMA and apoptosis through p53 posttranslational modification
not protein level. We believe this is the first comprehensive study
to date modeling radiation-induced ISC injury and protection using
crypt culture.
Results
PUMA deficiency strongly protects intestinal crypts and Lgr51
cells from radiation in culture. Our prior work indicated that
PUMA KO mice show blocked apoptosis, and improved DNA
repair and crypt regeneration through a p21-dependent
mechanism11,12. To directly investigate if these effects are epithelial
cell-intrinsic, we subjected cultured intestinal crypts isolated from
WT or PUMA KO mice to ionizing irradiation. The radiation
induced, dose-dependent suppression of growth and survival of
WT enteroid culture was observed 6 days after 4–8 Gy (Figure
S1A), which was significantly blocked in PUMA KO culture
(Figure 1A and Figure S1A). TUNEL and active caspase-3 staining
indicated that radiation induces marked apoptosis, which was
blocked by over 80% in the PUMA KO group (Figure 1B and
Figure S1B). We evaluated DNA damage and cell proliferation of
irradiated crypt culture using markers such as p-H2AX, Ki67 and
BrdU staining, and found reduced DNA double strand breaks and
improved cell proliferation within 24 h in the PUMA KO group
(Figure 1C, 1D and Figure S1C). Real-time PCR analysis showed a
strong induction of PUMA and p21 mRNA in the WT group 24 h
after radiation, and a higher increase of p21 in the PUMA KO group
(Figure 1E).
PUMA induction by radiation is p53-dependent and preferen-
tially in the intestinal stem and progenitor cells11. Using crypts from
the Lgr5-EGFP mice25, we found that apoptosis in the Lgr51 stem
cells was strongly suppressed in PUMA KO crypts (Figure 1F and
Figure S1B). Radiation rapidly reduced the expression of putative
ISCs markers Olfm4 and Lgr5 at 24 h, which was blunted in
PUMA KO crypts, while that of Bmi1 or Hopx was less sensitive to
radiation or PUMA loss (Figure 1G). These results demonstrate radi-
ation-induced crypt injury and Lgr51 cell apoptosis is mediated via
p53 and PUMA in a cell-intrinsic manner.
CHIR99021 protects crypts and Lgr51 cells against radiation in
culture. Using the crypt culture system, we screened nearly 20
compounds that have been shown to improve self-renewal or
reprogramming in various systems, and identified GSK-3 inhibitor
CHIR99021 as the most potent radiation protector. CHIR99021
treatment improved enteroid survival by over 3-fold six days after
5 Gy of radiation (Figure 2A). CHIR99021 significantly blocked
apoptosis (Figure 2B and Figure S2A) and accumulation of p-H2AX
positive cells (Figure 2C and Figure S2B), and enhanced proliferation at
24 h (Figure 2D and Figure S2C-D). CHIR99021 treatment also
protected Lgr51 cells against radiation-induced apoptosis (Figure 2E
and Figure S2A), and prevented the decrease in Olfm4, Lgr5 and CD44,
but not Bmi1 or Hopx (Figure 2F).
CHIR99021 blocks radiation-induced PUMA induction in crypt
culture through a p53-dependent mechanism. We further
investigated potential regulation of the p53 pathway by CHIR99021.
Interestingly, CHIR99021 treatment did not affect p53 stabilization or
phosphorylation (S18), but significantly blocked p53 acetylation
(K120) (Figure 3A), which was suggested to be mediated by GSK-3-
dependent phosphorylation (S86) and activation of Tip6023. Indeed,
phosphorylation of Tip60 (S86) was strongly inhibited (Figure 3A).
CHIR99021 treatment suppressed induction of PUMA, but not p21, at
mRNA and protein levels (Figure 3A and 3B). Importantly, adenoviral
expression of PUMA (Ad-PUMA)26 abrogated radioprotection by
CHIR99021 (Figure 3C and 3D). Several growth factors such as
bFGF1 and IGF1 have been shown to suppress radiation-induced
crypt apoptosis by preventing p53 accumulation and PUMA
induction in mice1,27. bFGF1 and IGF1 were found to significantly
improve the survival of irradiated crypts in culture by blocking
apoptosis and PUMA induction, which was associated with elevated
phosphorylation of AKT and GSK-3b (S9, inhibitory) (Figure S2E-F,
and data not shown). These results strongly suggest that CHIR99021
blocks p53-dependent induction of apoptosis and PUMA by
preventing TIP60-mediated p53 acetylation.
CHIR99021 protects mice and Lgr51 cells against radiation-
induced lethal GI injury. Small molecules can be subjected to
complex metabolism in vivo. Therefore, we determined the efficacy
of CHIR99021 inmice. CHIR99021 (2 mg/kg) given once, 4 h before
irradiation, significantly improved survival after 14.5 Gy abdominal
irradiation (ABI) (Figure 4A). Using total body irradiation (TBI), we
analyzed several well-characterized endpoints for radiation-induced
GI injury and regeneration, including apoptosis at 4 h, DNA damage
at 24 h, and crypt regeneration at 96 h. Consistent with our in vitro
data, CHIR99021 treatment significantly blocked crypt apoptosis
(Figure 4B and Figure S3A) and accumulation of p-H2AX1 cells
(Figure 4C), and improved crypt regeneration and villus height
(Figure 4D, 4E, Figure S3B). CHIR99021 treatment increased
Lgr51 cell survival by blocking apoptosis (Figure 4F, Figure S3C
and S3D), and effectively prevented the reduction of Olfm4, Lgr5
and CD44 as early as 4 h (Figure 4G). The expression of Bmi1 or
Hopx was less sensitive to radiation or CHIR99021 treatment
(Figure 4G). These results indicate CHIR99021 strongly protects
mice, specifically Lgr51 cells, in radiation-induced lethal GI injury
in vivo.
CHIR99021 inhibits p53-dependent induction of PUMA by irra-
diation in mice. We then examined the effects of CHIR99021
treatment on the p53 pathway in the small intestinal mucosa.
Consistent with the data from cultured crypts, CHIR99021
treatment blocked Tip60 phosphorylation, p53 acetylation and
induction of PUMA, but not stabilization or phosphorylation of
p53 or induction of p21 (Figure 5A and 5B). The levels of p-H2AX
did not significantly differ in the control and CHIR99021 at 4 h,
but significantly decreased at 24 h in CHIR99021-treated mice
(Figure 5C). H2AX foci can result from DNA cleavage during
apoptosis or death induction. Therefore, reduced H2AX foci in the
CHIR or PUMA KO group likely reflect reduced overall cellular
damage due to enhanced survival and some DNA repair indirectly.
We additionally examined the levels of several Bcl-2 family proteins
implicated in DNA damage-induced crypt apoptosis including Bax,
Bak, Bcl-2, Bcl-xL or Mcl-11, and did not observe significant changes
upon CHRI99021 treatment (Figure S4). The GSK-3 inhibitor
SB415286 was reported to suppress crypt apoptosis and Bax
expression after 4 or 8 Gy TBI28, but failed to block apoptosis or
PUMA induction in crypt culture or mice at the doses used in this
study (Figure S5). These results indicate that CHIR99021 selectively
ablates p53-dependent apoptosis and PUMA induction after
radiation in vivo.
CHIR99021 protects human intestinal stem cells against radiation
injury by PUMA inhibition. It has not been possible to directly
www.nature.com/scientificreports
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Figure 1 | PUMAdeficiency protects crypt culture and Lgr51 cells against radiation by blocking apoptosis. Small intestinal crypts fromWTand PUMA
KO mice were plated in Matrigel and subjected to 5 Gy, or mock (Un) irradiation, 24 h after plating and harvested at the indicated time points.
(A) Representative pictures of enteroids at day 6 and quantitation of enteroids with 5 ormore buds. (B) Apoptosis was assessed by TUNEL staining at 24 h
in WT and PUMA KO crypts. Left, representative pictures of TUNEL (green) staining. Right, quantitation of TUNEL index. (C) Representative pictures
and quantitation of p-H2AX staining in cultured crypts at 4 and 24 h. (D) Representative pictures and quantitation of Ki 67 staining in cultured crypts at
24 h. (E) Expression of PUMA and p21 transcripts was analyzed by real-time RT-PCR. (F) Crypts were isolated from Lgr5-EGFP Cre-ER background.
Lgr51 apoptosis was assessed by TUNEL/GFP staining at 24 h. Left, representative pictures of TUNEL (green), Lgr5 (red) and nuclei (DAPI) staining.
Right, the percentage of Lgr51 crypts containing one or more TUNEL1 cells. (G) Expression ofOlfm4, Lgr5, Bmi1 andHopx transcripts was analyzed by
real-time RT-PCR. Values are means6 SD, n5 3 wells from three different mice with each genotype. ***P, 0.001, **P, 0.01. Scale bar, A, 100 mm; B,
C, D & F, 20 mm.
www.nature.com/scientificreports
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evaluate radiation response of normal human intestinal epithelial or
stem cells. We decided to investigate the effects of CHIR99021 in
human intestinal cultures established from two unrelated donors,
which contained all differentiated epithelial lineages (Figure S6A).
CHIR99021 was added to the intestinal culture (EL1) 24 h before
5 Gy radiation and found to significantly improve enteroid
formation at 10 days (Figure 6A). CHIR99021 treatment significantly
reduced apoptosis of the Olfm41 cells, DNA damage, and improved
cell proliferation as early as 24 h (Figure 6B and 6C, Figure S6B).
CHIR99021 treatment blocked induction of PUMA, but not p21
(Figure 6D and Figure S6C), and significantly increased the
expression of putative human ISC markers including Olfm4, Lgr5,
Ascl2 and CD44 (Figure 6E). Similar results were obtained from an
independent adult human intestinal culture with CHIR99021
treatment, including improved survival and growth of enteroids,
suppression of PUMA expression and increased expression of ISC
markers (Figure 6F and 6G, Figure S6D). Somewhat different from
the patterns in mouse crypt culture, the levels ofOlfm or CD44, but not
Figure 2 | CHIR99021 protects crypt culture against radiation and blocks apoptosis. CHIR99021 (2.5 mM) was added to crypts 24 hr prior to 5 Gy or
mock (Un) irradiation, and crypts were harvested at the indicated time points after radiation. (A) Representative pictures of enteroids at day 6 and
quantitation of enteroids with 5 or more buds. (B) Apoptosis was assessed by TUNEL staining at 24 h. Left, representative pictures of TUNEL (green)
staining. Right, quantitation of TUNEL index. (C) Quantitation of p-H2AX staining in cultured crypts 24 h after radiation. (D) Quantitation of Ki67
staining in cultured crypts 24 h after radiation. (E) Crypts were isolated from Lgr5-EGFP Cre-ER background. Apoptosis was assessed by TUNEL staining
at 24 h. Left, representative pictures of TUNEL (green), Lgr5 (red) and nuclei (DAPI) staining. Right, quantitation of Lgr51 crypts containing one or
more TUNEL1 cells. (F) Expression ofOlfm4, Lgr5, CD44, Bmi andHopx transcripts was analyzed by real-time RT-PCR. Values are means6 SD. n5 3
wells from three different mice in each group. ***P , 0.001, **P , 0.01, *P , 0.05. Scale bar, A, 100 mm; B & E, 20 mm.
www.nature.com/scientificreports
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Lgr5, decreased significantly within 24 h of radiation, while all four
Wnt targets were highly induced by CHIR99021 treatment. This might
reflect species-specific growth kinetics, Wnt responsiveness, a
requirement for culture additives, or an inherent difficulty using
Wnt targets as ISC markers during injury and regeneration. These
results demonstrate that CHIR99021 protects human intestinal stem
cells from radiation by blocking p53-dependent induction of apoptosis
and PUMA.
Discussion
There has been a growing interest to develop agents for the manage-
ment of both short-term and long-term radiation injury in cancer
patients, cancer survivors and victims of radiation disasters2,3,8,9. In
this study, using crypt culture24,29, we demonstrate that p53-depend-
ent apoptosis mediates radiation-induced acute ISC and crypt injury
via a cell-intrinsic mechanism as suggested by in vivo studies1,11,27,30.
We then identified CHIR99021 as a potent radiation protector of
intestinal stem cells inmouse and human by selectively blocking p53-
dependent induction of PUMA and apoptosis through Tip60-
mediated posttranslational modification, without affecting the levels
of p53 or p21 induction (Figure S6E).
Following DNA damage, p53 protein is stabilized and undergoes
extensive modifications, and activating apoptosis in a tissue- and cell
type-specific manner31,32. Our work is in agreement with the model
that the modifications, not just levels of total protein, of p53
are responsible for radiation-induced apoptosis in human and
mouse ISCs, which is likely to be mediated through the GSK-3-
dependent Tip60 phosphorylation and p53 acetylation20–23 and
inhibited by CHIR99021 (Figure S6E). This mechanism is distinct
from preventing p53 accumulation by other GSK-3 inhibitor
SB41528618 or growth factors27. Targeting p53 modifications might
provide a novel way of combating p53-dependent and tissue-specific
radiation toxicity. Since GSK-3 can be regulated by Wnt or NF-kB
signaling15,33, it will be interesting to determine if suppression of
apoptosis via the GSK-3/p53/PUMA axis is responsible for GI pro-
tection provided by R-spondin1 or Toll-like receptor (TLR) agonists
(reviewed in Ref. 4). These studies might reveal potentially novel
regulation of p53-mediated DNA damage response by Wnt or NF-
kB signaling.
A major concern in normal tissue protection during cancer treat-
ment is tumor cell protection. p53 or its function is lost in most
human cancers and associated with therapeutic resistance34,35.
Unlike p53 KO mice, PUMA KO mice are highly resistant to radi-
ation-induced lethal GI and bone marrow injury11,36,37. Additionally,
PUMA KO mice show little or even reduced risk of cancer after
radiation (as much as 28 Gy in 4 rounds of TBI)38,39 by preventing
compensatory proliferation and clonal expansion of damaged cells.
In addition, p53-dependent apoptosis might be compromised in p53
Figure 3 | CHIR99021 inhibits p53-dependent PUMA induction and p53 K120-acetylation. Crypt culture were subjected to 5 Gy, or mock (Un)
irradiation and harvested at indicated time points. (A) The expression of indicated proteins at 24 h in cultured crypts (3 wells pooled) was determined by
western blotting. b-actin (Actin) was used as the control for loading. (B) Expression of PUMA and p21 transcripts was analyzed by real-time RT-PCR.
(C) Cultured crypts were infected with an adenovirus encoding PUMA (Ad-PUMA) for 24 h, and PUMAmRNA levels and protein (HA) were analyzed
by real-time RT-PCR andwestern blotting. (D) Cultured crypts were infected by Ad-PUMA at the same timewith or without CHIR99021 treatment. Left,
quantitation of enteroids with 5 ormore buds at day 4.Right, representative pictures of enteroids at day 4. Scale bar, 100 mm.Values aremeans6 SD, n5
3 wells from three different mice in each group. ***P , 0.001, **P , 0.01, *P , 0.05.
www.nature.com/scientificreports
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Figure 4 | CHIR99021 protects mice from radiation-induced lethal GI injury. WT C57BL/6 mice were injected intraperitoneally with CHIR99021
(2 mg/kg) or vehicle (dimethyl sulfoxide) 4 h prior to 14.5 Gy ABI (A) or 15 TBI (B-G). (A) Survival curves of mice after ABI. n5 10mice in each group.
(B) Apoptosis in the intestinal crypts 4 h after TBI was assessed by TUNEL staining (brown). Left, representative pictures of TUNEL staining. Right,
quantitation of TUNEL index. (C) Representative pictures and quantitation of p-H2AX staining in the intestinal crypts 4 h and 24 h after TBI.
(D) Representative pictures of regenerated crypts identified by BrdU staining 96 h after TBI (brown). (E) Quantitation of regenerated crypts (left) and
villus height (right) in D. (F) TUNEL staining in the crypts of Lgr5-EGFP;Cre-ERmice 4 h after TBI. Left, representative pictures of TUNEL (green), Lgr5
(red) and nuclei (DAPI) staining.Right, quantitation of Lgr51 crypts containing one ormore TUNEL1 cells. (G) Expression ofOlfm4, Lgr5,CD44,Bmi1
andHopx transcripts was analyzed by real-time RT-PCR. (B-G), values are means6 SD, n5 3mice in each group. ***P, 0.001, **P, 0.01, *P, 0.05.
Scale bar, 25 mm.
www.nature.com/scientificreports
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WT cancer due to frequent activation of the PI3K/AKT/mTOR or
Ras/Raf/ERK pathways40,41. Thus, targeting p53-dependent apopto-
sis likely offers a high level of selectivity for radiation protection in
normal tissue, but not p53-deficient cancer cells.
The critical cell populations in radiation-induced GI injury and
regeneration are still heavily debated mainly due to lack of reliable
markers4. Mounting evidence indicates Lgr51 cells are critical for
crypt regeneration after radiation while the CBCs are rapidly deleted
during acute intestinal injury (this study)7,42–44. Our data on
CHIR99021, PUMA KO and those on Wnt agonists including R-
spondin145–47 supports that Lgr51 cell protection reduces GI injury
and improves crypt regeneration in the setting of GI syndrome. We
found that Lgr51 cell protection is accompanied by maintained or
increased expression of Wnt-responsive transcripts such as Olfm4,
Lgr5 and CD44, but much less so on Bmi1 or Hopx. Lgr51 cell
protection and expansion might be beneficial for several reasons,
not mutually exclusive, such as increased clonogenic cells and pre-
venting the collapse of ‘‘the niche’’ to facilitate DNA repair. Since
transcription is halted in cells undergoing apoptosis, it is plausible
that increased cell survival preferentially elevates short-lived
transcripts such as Lgr5 or Olfm4, over the long-lived ones.
Characterization of radiation resistant ISCs will likely provide more
insight.
In summary, we identified GSK-3 inhibitor CHIR99021 as an
intestinal radioprotector in mice and humans by selectively blocking
p53-dependent apoptosis and PUMA induction in intestinal stem
and progenitor cells. These findings suggest a novel approach for
radiation protection of normal intestinal stem cells, but not p53-
deficient cancer cells, and suggest crypt culture as a useful model
for studying cell-intrinsic DNA damage responses of ISCs.
Methods
Mice. The procedures for all animal experiments were approved by the Institutional
Animal Care and Use Committee of the University of Pittsburgh. The procedures
were carried out in "accordance" with the approved guidelines. Mice 6–10 weeks old
were used. The PUMA1/1 and PUMA2/2 littermates on C57BL/6 background (F10)48
and Lgr5-EGFP (Lgr5-EGFP-IRES-creERT2) mice25 have been described. Mice were
subjected to whole body irradiation (TBI)11, or abdominal irradiation (ABI) as
described30. Mice were injected intraperitoneally (i.p.) with 2 mg/kg of CHIR99021
(Cat# C-6556, LC Laboratories, Woburn, MA) 4 h before radiation or 1 mg/kg of
SB415286 (Cat# 1617, Tocris bioscience, Ellisville, MO) 28 h and 4 h before
radiation. Mice were sacrificed to collect small intestines for histology analysis and
western blotting. All mice were injected i.p. with 100 mg/kg of BrdU (Cat# 858811,
Sigma-Aldrich) before sacrifice. Three or more mice were used in each group. More
details are found in supplemental material.
Small intestinal crypt and cell isolation, culture and treatment. Mouse crypts
were isolated and cultured in Matrigel with a cocktail of factors as previously
described in 24-well plates in crypt culture medium (Advanced DMEM/F12
containing 50 ng/ml EGF, 100 ng/ml Noggin, 500 ng/ml human R-spondin 1,
1 mM N-Acetylcysteine, 1% N2 supplement and B27 supplement)24,42. Other
agents used include CHIR99021 (2.5 mM), SB415286 (2.5 mM), bFGF (400 ng/ml),
IGF1 (100 ng/ml), Ad-PUMA (0.22 ml/well)26, which was added to the culture
24 h before radiation. Two human intestinal cultures were established from either
single cell suspension or enriched crypt preparations with slightly different culture
additives as detailed in supplemental materials. Similar results were obtained from
at least three independent experiments using two or more donors (mice or
human), and triplicate wells were included in each experiment. More details are
found in supplemental material.
Western blotting. Total protein was prepared from freshly isolated small intestine
and cultured crypts, separately, and western blotting was performed as previously
described42. Details on antibodies are found in supplemental material.
Total RNA extraction and real-time reverse transcription PCR. Total RNA was
isolated from tissues and cultured crypts using the Mini-RNA Isolation II Kit (Cat#
R1055, Zymo Research) according to the manufacturer’s protocol. Complementary
DNA was generated using SuperScript III reverse transcriptase (Invitrogen). Real-
time PCR was performed on CFX96 (Bio-Rad, Hercules, CA) with SYBR Green
(Invitrogen, Carlsbad, CA)11,42. Detailed sequences for real-time PCR are found in
supplementary tables (Table S1 and S2).
Immunohistochemistry (IHC) and immunofluorescence (IF), TUNEL, BrdU
staining, crypt microcolony assay. Slides were processed and stained as
described11,12,30. Details are found in supplemental material.
Statistical analysis. Statistical analysis was carried out using GraphPad Prism V
software. The survival data were analyzed by log-rank test. Data were presented as
means 6 S.D. Statistical significance was calculated with unpaired student’s t-test.
P , 0.05 was considered to be significant. The means 6 1 S.D. are displayed in the
Figure 5 | CHIR99021 suppresses induction of PUMA and p53 K120 acetylation by radiation in mice. Intestinal mucosa of WT mice were harvested
after 15 Gy TBI with or without CHIR99021 treatment (2 mg/kg) 4 h prior to radiation. (A) The expression of indicated proteins at 4 h was analyzed by
western blotting. b-actin was used as the control for loading. (B) ThemRNA expression of PUMA and p21was analyzed by real-time RT-PCR. Values are
means6 SD. n5 3mice in each group. ***P, 0.001, **P, 0.01. (C) The expression of p-H2AX (pooled from 3mice) was analyzed by western blotting.
The lysates were pooled from 3 mice.
www.nature.com/scientificreports
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Figure 6 | CHIR99021 protects human intestinal culture and stem cells against radiation injury.Two independent human intestinal cultures, EL1 (A-E)
and MM1 (F-G), were plated and passaged in Matrigel as described in methods. CHIR99021 (2.5 mM) was added to culture medium 24 h before
5 Gy radiation, and cultures were harvested at indicated times after radiation. (A) Representative pictures of enteroids at day 10 and quantitation of
enteroids$100 mm. (B) Apoptosis of was assessed by TUNEL staining at 24 h. Olfm4 labels putative stem cells. Left, representative pictures of TUNEL
(green), Olfm4 (red) and nuclei (DAPI) staining. Middle, quantitation of TUNEL index. Right, quantitation of Olfm41 cells containing one or more
TUNEL1 cells. (C) Representative pictures (left) and quantitation of p-H2AX staining (right) 24 h after radiation. (D) Expression of PUMA and p21
transcripts was analyzed by real-timeRT-PCR. (E) Expression ofOlfm4, Lgr5,Ascl2 andCD44 transcripts was analyzed by real-time RT-PCR. (F) Enteroid
growth ofMM1 culture was analyzed at day 6. (G) The expression of PUMA and p21 transcripts inMM1 culture at 24 h was analyzed by RT-PCR. Values
are means 6 SD, n 5 3 wells. ***P , 0.001, **P , 0.01. Scale bar, A and F, 200 mm; B and C, 30 mm.
www.nature.com/scientificreports
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figures where applicable. For crypt culture experiments, results of a representative
experiment using 3 triplicate wells were shown.
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